Stock Track | Evolent Health Plummets 5.33% as Multiple Analysts Cut Price Targets

Stock Track

Nov 07, 2025

Evolent Health (EVH) saw its stock price plummet by 5.33% in pre-market trading on Friday, following a series of price target cuts by multiple Wall Street analysts. The healthcare sector company faced a significant setback as analysts reassessed its valuation amid near-term challenges.

Leading the downgrades, TD Cowen slashed its price target for Evolent Health to $8 from $14, signaling a substantial reduction in the firm's expectations for the stock. This was followed by BTIG, which lowered its target price to $16 from $20, further contributing to the negative sentiment surrounding the company.

While specific reasons for the downgrades were not immediately clear, the coordinated nature of these price target cuts suggests that analysts may be concerned about Evolent Health's near-term growth prospects or potential headwinds in the healthcare sector. Despite these challenges, some analysts, like Charles Rhyee from TD Cowen, maintained a positive long-term outlook on the company, hinting at potential strategic growth opportunities that could materialize in the future.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1136342646"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1136342646\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1136342646?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 23:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1136342646","market":"us","top_or_hot":-1,"title":"Stock Track | Evolent Health Plummets 5.33% as Multiple Analysts Cut Price Targets","media":"Stock Track","content":"<p>Evolent Health (EVH) saw its stock price plummet by 5.33% in pre-market trading on Friday, following a series of price target cuts by multiple Wall Street analysts. The healthcare sector company faced a significant setback as analysts reassessed its valuation amid near-term challenges.</p>\n\n<p>Leading the downgrades, TD Cowen slashed its price target for Evolent Health to $8 from $14, signaling a substantial reduction in the firm's expectations for the stock. This was followed by BTIG, which lowered its target price to $16 from $20, further contributing to the negative sentiment surrounding the company.</p>\n\n<p>While specific reasons for the downgrades were not immediately clear, the coordinated nature of these price target cuts suggests that analysts may be concerned about Evolent Health's near-term growth prospects or potential headwinds in the healthcare sector. Despite these challenges, some analysts, like Charles Rhyee from TD Cowen, maintained a positive long-term outlook on the company, hinting at potential strategic growth opportunities that could materialize in the future.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Evolent Health Plummets 5.33% as Multiple Analysts Cut Price Targets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Evolent Health Plummets 5.33% as Multiple Analysts Cut Price Targets\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-07 23:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Evolent Health (EVH) saw its stock price plummet by 5.33% in pre-market trading on Friday, following a series of price target cuts by multiple Wall Street analysts. The healthcare sector company faced a significant setback as analysts reassessed its valuation amid near-term challenges.</p>\n\n<p>Leading the downgrades, TD Cowen slashed its price target for Evolent Health to $8 from $14, signaling a substantial reduction in the firm's expectations for the stock. This was followed by BTIG, which lowered its target price to $16 from $20, further contributing to the negative sentiment surrounding the company.</p>\n\n<p>While specific reasons for the downgrades were not immediately clear, the coordinated nature of these price target cuts suggests that analysts may be concerned about Evolent Health's near-term growth prospects or potential headwinds in the healthcare sector. Despite these challenges, some analysts, like Charles Rhyee from TD Cowen, maintained a positive long-term outlook on the company, hinting at potential strategic growth opportunities that could materialize in the future.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EVH","symbol_name":"Evolent Health Inc","start_time":0,"source_url":"","article_id":"1136342646","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1136342646","pubTimestamp":1762528451,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Evolent Health (EVH) saw its stock price plummet by 5.33% in pre-market trading on Friday, following a series of price target cuts by multiple Wall Street analysts. The healthcare sector company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EVH":"Evolent Health Inc"},"translate_title":"个股追踪|Evolent Health暴跌5.33%多分析师下调目标价","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EVH":1},"content_text":"Evolent Health (EVH) saw its stock price plummet by 5.33% in pre-market trading on Friday, following a series of price target cuts by multiple Wall Street analysts. The healthcare sector company faced a significant setback as analysts reassessed its valuation amid near-term challenges.\nLeading the downgrades, TD Cowen slashed its price target for Evolent Health to $8 from $14, signaling a substantial reduction in the firm's expectations for the stock. This was followed by BTIG, which lowered its target price to $16 from $20, further contributing to the negative sentiment surrounding the company.\nWhile specific reasons for the downgrades were not immediately clear, the coordinated nature of these price target cuts suggests that analysts may be concerned about Evolent Health's near-term growth prospects or potential headwinds in the healthcare sector. Despite these challenges, some analysts, like Charles Rhyee from TD Cowen, maintained a positive long-term outlook on the company, hinting at potential strategic growth opportunities that could materialize in the future.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}